Anne Burden

1.7k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Anne Burden is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Anne Burden has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 2 papers in Epidemiology. Recurrent topics in Anne Burden's work include Asthma and respiratory diseases (20 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (11 papers). Anne Burden is often cited by papers focused on Asthma and respiratory diseases (20 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (11 papers). Anne Burden collaborates with scholars based in United Kingdom, France and United States. Anne Burden's co-authors include David Price, Mike Thomas, Elizabeth V. Hillyer, A WILSON, Anna Rigazio, Alison Chisholm, Julie von Ziegenweidt, Christopher J. Corrigan, Gokul Gopalan and Sally E. Wenzel and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Anne Burden

25 papers receiving 1.3k citations

Hit Papers

Blood eosinophil count and prospective annual asthma dise... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
    2015 413 citations David Price, Anna Rigazio et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Burden United Kingdom 17 1.0k 997 137 98 91 27 1.3k
Carl Johan Lamm Sweden 9 1.1k 1.1× 967 1.0× 84 0.6× 120 1.2× 87 1.0× 11 1.3k
Tiago Jacinto Portugal 17 649 0.6× 546 0.5× 71 0.5× 162 1.7× 59 0.6× 62 908
Tunn Ren Tay Singapore 16 712 0.7× 639 0.6× 95 0.7× 188 1.9× 53 0.6× 39 967
David R. Mink United States 14 565 0.6× 548 0.5× 51 0.4× 90 0.9× 52 0.6× 24 804
Anne Pietinalho Finland 22 1.3k 1.2× 1.2k 1.2× 76 0.6× 93 0.9× 39 0.4× 33 1.5k
Mary K. Miller United States 16 596 0.6× 484 0.5× 101 0.7× 149 1.5× 112 1.2× 34 1.0k
Paula Kauppi Finland 21 799 0.8× 561 0.6× 102 0.7× 231 2.4× 140 1.5× 77 1.2k
Alicia Padilla‐Galo Spain 16 417 0.4× 587 0.6× 57 0.4× 81 0.8× 52 0.6× 54 730
Nicola Ullmann Italy 19 660 0.6× 646 0.6× 273 2.0× 106 1.1× 287 3.2× 57 1.3k
J O Warner United Kingdom 18 341 0.3× 793 0.8× 199 1.5× 63 0.6× 74 0.8× 30 1.1k

Countries citing papers authored by Anne Burden

Since Specialization
Citations

This map shows the geographic impact of Anne Burden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Burden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Burden more than expected).

Fields of papers citing papers by Anne Burden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Burden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Burden. The network helps show where Anne Burden may publish in the future.

Co-authorship network of co-authors of Anne Burden

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Burden. A scholar is included among the top collaborators of Anne Burden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Burden. Anne Burden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dollerup, Jens, Jørgen Vestbo, Tarita Murray‐Thomas, et al.. (2017). Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study. Clinical Epidemiology. Volume 9. 231–243. 16 indexed citations
3.
Chrystyn, Henry, David Price, Mathiéu Molimard, et al.. (2016). Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study. BMC Pulmonary Medicine. 16(1). 12–12. 26 indexed citations
4.
Price, David, Richard Russell, Rafael Marés, et al.. (2016). Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study. PLoS ONE. 11(9). e0162903–e0162903. 62 indexed citations
5.
Turner, Steve, Kathryn Richardson, Clare Murray, et al.. (2016). Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids. The Journal of Allergy and Clinical Immunology In Practice. 5(1). 99–106.e3. 13 indexed citations
6.
King, Christine, David Price, A WILSON, et al.. (2016). Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. Journal of Asthma and Allergy. 9. 1–1. 163 indexed citations
7.
Roche, Nicolás, Gene Colice, Elliot Israel, et al.. (2016). Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist. Pulmonary Therapy. 2(1). 73–89. 1 indexed citations
8.
Roche, Nicolás, Dirkje S. Postma, Gene Colice, et al.. (2015). Differential Effects of Inhaled Corticosteroids in Smokers/Ex-Smokers and Nonsmokers with Asthma. American Journal of Respiratory and Critical Care Medicine. 191(8). 960–964. 21 indexed citations
9.
Israel, Elliot, Nicolás Roche, Richard J. Martin, et al.. (2015). Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma. Annals of the American Thoracic Society. 12(6). 798–806. 18 indexed citations
10.
King, Christine, David Price, Alan Kaplan, et al.. (2015). Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide. Journal of Asthma and Allergy. 8. 1–1. 40 indexed citations
11.
Price, David, Anna Rigazio, Jonathan D. Campbell, et al.. (2015). Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. The Lancet Respiratory Medicine. 3(11). 849–858. 413 indexed citations breakdown →
12.
Carter, Victoria, Henry Chrystyn, Anne Burden, et al.. (2015). Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. Journal of Asthma. 53(3). 321–329. 85 indexed citations
13.
Grigg, Jonathan, Theresa W. Guilbert, Nicolás Roche, et al.. (2015). Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma. The Journal of Allergy and Clinical Immunology In Practice. 3(5). 721–731.e16. 33 indexed citations
14.
Price, David, Dirkje Postma, Nicolás Roche, et al.. (2014). Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD. International Journal of COPD. 9. 1163–1163. 25 indexed citations
15.
Jones, Rupert, David Price, Dermot Ryan, et al.. (2014). Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. The Lancet Respiratory Medicine. 2(4). 267–276. 136 indexed citations
16.
Martin, Richard J., David Price, Nicolás Roche, et al.. (2014). Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study. npj Primary Care Respiratory Medicine. 24(1). 14081–14081. 17 indexed citations
17.
Price, David, Mike Thomas, John Haughney, et al.. (2013). Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma. Respiratory Medicine. 107(7). 987–1000. 42 indexed citations
18.
Colice, Gene, Richard J. Martin, Elliot Israel, et al.. (2013). Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. Journal of Allergy and Clinical Immunology. 132(1). 45–54.e10. 50 indexed citations
19.
Ryan, Dermot, Feargal J. Ryan, Dinesh Saralaya, et al.. (2012). P276 The Impact of the Optimum Patient Care Service on Outcomes for Adult Asthmatic Patients: Abstract P276 Table 1. Thorax. 67(Suppl 2). A186.1–A186.
20.
Barnes, Neil, David Price, Gene Colice, et al.. (2011). Asthma control with extrafine‐particle hydrofluoroalkane–beclometasone vs. large‐particle chlorofluorocarbon–beclometasone: a real‐world observational study. Clinical & Experimental Allergy. 41(11). 1521–1532. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl Johan Lamm Breakdown of academic impact, for papers by Tiago Jacinto Breakdown of academic impact, for papers by Tunn Ren Tay Breakdown of academic impact, for papers by David R. Mink Breakdown of academic impact, for papers by Anne Pietinalho Breakdown of academic impact, for papers by Mary K. Miller Breakdown of academic impact, for papers by Paula Kauppi Breakdown of academic impact, for papers by Alicia Padilla‐Galo Breakdown of academic impact, for papers by Nicola Ullmann Breakdown of academic impact, for papers by J O Warner
Rankless by CCL
2026